(Q52905842)

9 May 2018

title

Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial. (English)

1 reference

9 May 2018

9

Gérard Socié

1 reference

9 May 2018

Birte Friedrichs

1

1 reference

9 May 2018

André Tichelli

2

1 reference

9 May 2018

Andrea Bacigalupo

3

1 reference

9 May 2018

Nigel H Russell

4

1 reference

9 May 2018

Tapani Ruutu

5

1 reference

9 May 2018

Michael Y Shapira

6

1 reference

9 May 2018

Meral Beksac

7

1 reference

9 May 2018

Dirk Hasenclever

8

1 reference

9 May 2018

Norbert Schmitz

10

1 reference

9 May 2018

publication date

30 January 2010

1 reference

9 May 2018

Lancet Oncology Commission

published in

1 reference

9 May 2018

volume

11

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

page(s)

331-338

1 reference

9 May 2018

The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Part II: management of resistance to imatinib in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first compl

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Solid cancers after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Nonmalignant late effects after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970352-3

7 January 2021

10.1016/S1470-2045(09)70352-3

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018